These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19474297)

  • 21. RNA-Seq and expression microarray highlight different aspects of the fetal amniotic fluid transcriptome.
    Zwemer LM; Hui L; Wick HC; Bianchi DW
    Prenat Diagn; 2014 Oct; 34(10):1006-14. PubMed ID: 24852236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S100B content and SOD activity in amniotic fluid of pregnancies with Down syndrome.
    Netto CB; Siqueira IR; Fochesatto C; Portela LV; da Purificação Tavares M; Souza DO; Giugliani R; Gonçalves CA
    Clin Biochem; 2004 Feb; 37(2):134-7. PubMed ID: 14725944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the mitochondrial ATPase6 gene and Tfam in Down syndrome.
    Lee SH; Lee S; Jun HS; Jeong HJ; Cha WT; Cho YS; Kim JH; Ku SY; Cha KY
    Mol Cells; 2003 Apr; 15(2):181-5. PubMed ID: 12803480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amniotic fluid biomarkers are linked to oxidative stress in Down syndrome.
    Expert Rev Mol Diagn; 2011 May; 11(4):359. PubMed ID: 21696011
    [No Abstract]   [Full Text] [Related]  

  • 25. Pyridoxine-related metabolite concentrations in normal and Down syndrome amniotic fluid.
    Baggot PJ; Eliseo AJ; DeNicola NG; Kalamarides JA; Shoemaker JD
    Fetal Diagn Ther; 2008; 23(4):254-7. PubMed ID: 18417989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathway not taken: understanding 'omics data in the perinatal context.
    Edlow AG; Slonim DK; Wick HC; Hui L; Bianchi DW
    Am J Obstet Gynecol; 2015 Jul; 213(1):59.e1-59.e172. PubMed ID: 25772209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative proteomic analysis of human amniotic fluid supernatants with Down syndrome using mass spectrometry.
    Park J; Cha DH; Jung JW; Kim YH; Lee SH; Kim Y; Kim KP
    J Microbiol Biotechnol; 2010 Jun; 20(6):959-67. PubMed ID: 20622492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the cell-free amniotic fluid transcriptome expressed during the euploid mid-trimester of pregnancy.
    Jung YW; Shim SS; Park JE; Sung SR; Shim SH; Park HR; Cha DH
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():94-8. PubMed ID: 27261819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble interleukin-2 receptor and interleukin-2 in human amniotic fluid of normal and abnormal pregnancies.
    Shohat B; Shohat M; Faktor JH; Barkay G; Harell D; Kozenitzky L; Shohat M
    Biol Neonate; 1993; 63(5):281-4. PubMed ID: 8353155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome.
    Tsangaris GT; Karamessinis P; Kolialexi A; Garbis SD; Antsaklis A; Mavrou A; Fountoulakis M
    Proteomics; 2006 Aug; 6(15):4410-9. PubMed ID: 16847874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organic acid concentrations in amniotic fluid found in normal and Down syndrome pregnancies.
    Baggot PJ; Eliseo AJ; DeNicola NG; Kalamarides JA; Shoemaker JD
    Fetal Diagn Ther; 2008; 23(3):245-8. PubMed ID: 18417986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA microarray analysis of channels and transporters in normal and fetal Down syndrome (trisomy 21) brain.
    Lubec G; Sohn SY
    J Neural Transm Suppl; 2003; (67):215-24. PubMed ID: 15068253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.
    Guedj F; Siegel AE; Pennings JLA; Alsebaa F; Massingham LJ; Tantravahi U; Bianchi DW
    Am J Hum Genet; 2020 Nov; 107(5):911-931. PubMed ID: 33098770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amniotic fluid angiogenin levels are decreased in pregnancies with fetal trisomy 21.
    Demir A; Guclu S; Bige O; Solak A; Demir N
    Prenat Diagn; 2011 Nov; 31(11):1101-3. PubMed ID: 21800332
    [No Abstract]   [Full Text] [Related]  

  • 35. Urocortin in amniotic fluid and Down syndrome.
    Torricelli M; Voltolini C; Biliotti G; Giorlandino C; De Pascalis F; De Bonis M; Mesuraca A; Giovannelli A; Pecciarini L; Petraglia F
    Prenat Diagn; 2009 Aug; 29(8):806-7. PubMed ID: 19418477
    [No Abstract]   [Full Text] [Related]  

  • 36. Specificity and sensitivity of S100B levels in amniotic fluid for Down syndrome diagnosis.
    Tort AB; Portela LV; da Purificação Tavares M; Gonçalves CA; Netto C; Giugliani R; Souza DO
    Life Sci; 2004 Dec; 76(4):379-84. PubMed ID: 15530500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury.
    Esposito G; Imitola J; Lu J; De Filippis D; Scuderi C; Ganesh VS; Folkerth R; Hecht J; Shin S; Iuvone T; Chesnut J; Steardo L; Sheen V
    Hum Mol Genet; 2008 Feb; 17(3):440-57. PubMed ID: 17984171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling in the adult Down syndrome brain.
    Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
    Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular weight forms of inhibin A, inhibin B and pro-alphaC in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies.
    Thirunavukarasu PP; Lambert-Messerlian G; Robertson DM; Dawson G; Canick J; Wallace EM
    Prenat Diagn; 2002 Dec; 22(12):1086-92. PubMed ID: 12454963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amniotic Fluid Angiogenic and Inflammatory Factor Profiling in Foetal Down Syndrome.
    Zbucka-Kretowska M; Charkiewicz K; Czerniecki J; Goscik J; Wolczynski S; Laudanski P
    Fetal Diagn Ther; 2018; 44(1):44-50. PubMed ID: 28715807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.